Topic Listing for Allergan

Acceleration Termination Employment Due Death Disability Job Elimination Accounting Defined Benefit Pension Other Postretirement Plans
Accounts Allocations Accrual Benefits
Acne Psoriasis Acquire Companies Future Acquisitions Disrupt Business
Acquired Domain Names Acquired Trademarks
Acquisitions Technologies Products Businesses Disrupt Business Involve Increased Aczone Asset Purchase
Additional Abbreviations Also Used Though Not Above List Additional Benefit Payment Rules
Adjustments Stock Splits Recapitalizations Mergers Administration 2008 Plan
Administration Plan Adoption Fin Accounting Uncertainties Income Taxes Interpretation Fasb
Adoption Sfas 158 Employers Accounting Defined Benefit Pension Adoption Statement Financial Accounting Standards 158 Employers Defined
Adverse International Economic Conditions Reduce Consumer Demand Products Adversely Affected Violations Foreign Corrupt Practices Act Similar
Advertising Expenses Against Stockholder Proposal
Agreement Apaziquone Eoquin Alienation Plan Benefits
Allergan Contacts Allergan Inc
Allergan Inc Contacts Allergan Inc Deferred Directors Fee Program
Allergan Inc Employee Recognition Stock Award Plan Allergan Inc Spectrum Pharmaceuticals Forward-looking Statements
Allergan Irish Share Participation Scheme Allergan Pharmaceuticals Ireland Ltd Inc Savings Related Share
Allergan Reports 2008 Operating Results Allergan Reports 2009 Operating Results
Allergan Usa Inc Allergans Test Warrants Attention Management Shareholders Several Reasons
Amended Restated Change Control Agreement Amendment Adoption Plan
Amendment Termination 2008 Plan Amendments Articles Incorporation Bylaws Change
Amortization Acquired Intangible Assets Announces Restructuring
Annual Base Salaries Annual Performance Incentive Awards
Annual Report Apaziquone
Appendix Applications
Approval Allergan Inc 2008 Incentive Award Plan Assets Liabilities Measured Fair Value Recurring Basis
Audit Finance Committee Audit Finance Committee Report
Automatic Grants Awards Non-employee Directors Award Limits
Base Salaries Base Salary
Basis Presentation Benchmarking Peer Group
Beneficial Ownership Reporting Compliance Benefits
Board Committees Board Directors Response Stockholder Proposal
Board Meetings Board Recommendation
Board Recommends Vote Against Stockholder Proposal Following Reasons Board Recommends Vote Election Each Named Director Nominees
Bonus Pool Calculation Bonus Pool Differentiation Business Unit Function
Bonuses Determined Executive Bonus Plan Bonuses Management Bonus Plan Executive
Breast Aesthetics Breast Implant Replacement Programs
Business Continue Expose Risks Environmental Liabilities Business Segment Information
Cameras Recording Equipment Electronic Devices Large Bags Briefcases Cash Equivalents
Certain Relationships Related Transactions Certain Remedies Notice Right
Certification Principal Executive Officer Certification Principal Financial Officer
Change Control Change Control Definition
Changes Consumer Marketplace Economic Conditions Adversely Affect Sales Chief Executive Officer
Choice Specified Proxy Voted Against Stockholder Proposal Class Nominees Election Annual Meeting
Class Nominees Election Annual Meeting Term Expire 2011 Class Nominees Election Annual Meeting Term Expire 2012
Class Term Expire Annual Meeting 2008 Class Term Expire Annual Meeting 2009
Class Term Expire Annual Meeting 2010 Class Term Expire Annual Meeting 2011
Co-promotion Agreement Code Business Conduct Ethics
Collaborative Partners Not Perform Unable Develop Market Products Commercialization Supply Agreement
Common Stock Split Compensation Committee Compares Levels Elements Those Provided Competitors
Compensation Committee Determination Awards Compensation Committee Determine Forms Amounts
Compensation Committee Interlocks Insider Participation Compensation Committee Retained Consultant
Compensation Committee Retention Consultant Compensation Committee Uses Tally Sheets
Compensation Discussion Analysis Compensation Objectives
Competition Compliance Extensive Government Regulations Subject Expensive Time Consuming
Comprehensive Income Loss Concentration Credit Risk
Confidential Information Confidentiality
Connection Esprit Acquisition 2007 Acquired New Product Line Consent Independent Registered Public Accounting Firm
Consolidation Drug Wholesalers Other Wholesaler Actions Increase Competitive Contacting Board Directors
Contingencies Continuing Operations
Contracts Checks Drafts Bank Accounts Etc Contractual Obligations Commitments
Contributions Contributions Allocation Accounts
Controls Procedures Convertible Notes
Cornéal Acquisition Corporate Governance Committee
Corporate Objectives Cost Sales
Costs Solicitation Critical Accounting Policies Estimates Assumptions
Dated 2008 Deferral Accounts
Deferral Elections Definitions
Definitions Interpretation Departure Directors Certain Officers Election Appointment Compensatory
Did Compensation Committee Adopt Clawback Policy Director Attendance Annual Meetings
Director Independence Disclosures
Discontinuance Contributions Disruption Certain Manufacturing Sites Significantly Interrupt Production Capabilities
Documents Incorporated Reference Earnings Continuing Operations
Earnings Loss Continuing Operations Earnings Per Share
Election Directors Eligibility
Eligibility Participation Employee Relations
Employee Retirement Other Benefit Plans Employee Stock Plans
Endoart Acquisition Environmental Matters
Eoquin Target Product Profile Document Equity Compensation Plan Information
Equity Ownership Guidelines Officers Directors Esprit Acquisition
Establishment Trust Estimated Future Benefit Payments
Estimates Evaluation Disclosure Controls Procedures
Exact Name Registrant Specified Charter Example Closed System Packaging
Example Royalties Executive Compensation
Executive Officers Executive Sessions
Executive Summary Experience Difficulties Delays Unexpected Costs Not Achieve Maintain
Experience Difficulties Obtaining Creating Raw Materials Components Needed Experience Difficulties Obtaining Creating Raw Materials Needed Produce
Experience Losses Due Product Liability Claims Recalls Corrections Eyelash Growth
Facial Aesthetics Failure Attract Retain Key Managerial Technical Scientific Selling
Failure Attract Retain Key Managerial Technical Selling Marketing Fair Value Financial Instruments
Fair Value Measurements Federal Income Tax Consequences Associated 2008 Plan
Fin Disclosures Financial Instruments
Financial Statements Exhibits Foreign Currency Fluctuations
Foreign Currency Translation Foreign Exchange Risk Management
Form 10-k Form Pensions
Former Name Address Changed Since Last Report Forward-looking Statements
Fund Media Funding
Future Success Depends Ability Develop New Products Indications General
General Overview Business General Provisions
Geographic Information Goodwill
Goodwill Intangible Assets Grant Equity Awards Compensation Committee Determine Amount Such
Guarantees Health Care Initiatives Other Third-party Payor Cost-containment Pressures
Hospitals Institutions Clinical Trial Sites Identifiable Intangible Asset
Identifiable Intangible Assets Illustration Closed-system Packaging
Impairment Evaluations Goodwill Purchased Intangible Assets Importation Products Canada Other Countries United States Intra-european
Importation Products Canada Other Countries United States Lower In-process Research Development
Inamed Acquisition Inamed Corporation
Incentive Compensation Plan Income Expenses
Income Taxes Incorporation Reference
Independent Registered Public Accounting Firms Fees Independent Registered Public Accounting Firms Independence Attendance Annual
Index Individual Bonus Award Calculation
Individual Objectives Inflation
Information Nominees Other Directors Initial Joint Marketing Plan
Intangibles Intangibles Goodwill
Intellectual Property Interest Rate Risk
Interest Rate Risk Management International Operations
Introduction Inventories
Investments Irvine
Issuer Purchases Equity Securities Joint Development Plan
Key Development Personnel Lap-band
Legal Proceedings License Development Supply Distribution Agreement
Limitation Allocations Liquidity Capital Resources
List Schedules List Subcontractors
Litigation Harm Business Otherwise Distract Management Long-lived Assets
Long-term Incentive Awards Stock Options Management Bonus Plan Executive
Managements Report Internal Control Over Financial Reporting Manufacturing
Market Products Manner Violates Health Care Fraud Abuse Medical Devices Segment
Medicare Prescription Drug Improvement Modernization Act 2003 Method Bonus Payment
Method Payment Minimum Expected Tpps
Miscellaneous Miscellaneous Provisions
Negative Conditions Financial Credit Markets Impact Liquidity Negative Publicity Concerning Safety Efficacy Products Harm Sales
Negative Publicity Concerning Safety Products Harm Sales Force Negative Publicity Concerning Safety Products Harm Sales Forced
Net Earnings Attributable Allergan Inc Net Earnings Loss
Net Periodic Benefit Cost Net Sales Product Line
Neuromodulator New Accounting Standards Not Yet Adopted
Non-employee Director Equity Incentive Plan Non-employee Directors Compensation
Non-operating Income Expense Non-operating Income Expenses
Nonqualified Deferred Compensation Table Notes Payable Long-term Debt
Obesity Intervention Officers
Offices Operate Highly Competitive Business
Operating Income Loss Operating Lease Obligations
Operating Procedures Operating Results
Operating Results Attributable Stockholders Operating Segments
Operations Option Exercises Stock Vested Table
Organization Compensation Committee Organization Compensation Committee Report
Other Other Alienation Plan Benefits
Other Financial Instruments Other Products
Other Regulations Other Restructuring Activities Integration Costs
Other Revenues Outlook
Outlook 2009 Ownership Real Property Operation Business Continue Expose Risks
Part Participant Deposits
Participation Party Coverage Reimbursement
Patents Trademarks Licenses Pay Mix Emphasizes Equity Compensation Risk
Payment Plan Benefits Peer Group
Pension Postretirement Benefit Plans Pensions
Performance Objectives Performance Objectives Bonus Amount Determination
Perquisites Other Benefits Plan Articles Through
Plan Benefits Policy Audit Finance Committee Pre-approval
Policy Deductibility Compensation Pre-retirement Death Benefits
Preferability Letter Independent Registered Public Accounting Firm Premium Priced Stock Option Plan
Pro Forma Results Operations Product Development Efforts Not Result Commercial Products
Product Net Sales Product Net Sales Line
Product Pipeline Update Product Sales
Product Warranties Profit Split Psmm Share Process
Proxy Properly Executed Voted Directed Direction Given Against Proxy Solicited Board Directors Annual Meeting Thursday 2009
Proxy Statement Pursuant Securities Exchange Act 1934 Publicly-filed Sec Reports Reviewed Time Significant Changes Required
Purchase Price Allocation Purpose 2008 Plan
Purpose Plan Quorum Required Vote
Ratification Independent Registered Public Accounting Firm Recently Adopted Accounting Standards
Recitals Reclassifications
Registrants Telephone Number Registrations
Reinvestment Rate Performance Remainder Page Intentionally Left Blank
Report Independent Registered Public Accounting Firm Report Organization Compensation Committee
Representations Warranties Covenants Research Development
Restated 2008 Restructuring
Restructuring Charges Integration Costs Transition Duplicate Operating Expenses Restructuring Charges Integration Transition Costs
Restructuring Integration Cornéal Operations Restructuring Integration Inamed Operations
Restructuring Phased Closure Arklow Facility Restructuring Plan
Restructuring Streamlining European Operations Restructuring Streamlining Operations Japan
Retirement Plans Revenue Recognition
Revoke Change Vote Risk Factors
Sales Expenses Sales Marketing
Samil Acquisition Savings Investment Plan
Savings Plan Employees Allergan Inc Schedule Allergan Inc Valuation Qualifying Accounts 2006 2005
Scheduled In-service Withdrawals Science Technology Committee
Seasonality Securities Authorized Issuance Equity Compensation Plans
Securities Registered Pursuant Act Securities Subject 2008 Plan
Selling General Administrative Severance Change Control Arrangements
Share-based Awards Share-based Compensation
Shares Transfer Signature
Signature Page Follow Signatures
Skin Care Product Line Skin Care Product Lines
Solicitation Proxies Allergans Board Directors Specialty Pharmaceuticals Segment
Specifications Spectrum Manufacturing Agreements
Spectrum Pharmaceuticals Inc Spectrum Pharmaceuticals Inc Contacts
Stockholder List Stockholder Nominations Directors
Stockholder Proposal Stockholder Proposals
Stockholder Proposals Annual Meeting Stockholder Proposals Inclusion Proxy Statement
Stockholders Holding Subject Intellectual Property Litigation Infringement Claims Cause Incur
Subject Risks Arising Currency Exchange Rates Increase Costs Subject Risks Associated Doing Business Internationally
Submission Matters Vote Security Holders Subsequent Event
Subsequent Events Summary Significant Accounting Policies
Supporting Statement Table Contents
Tabular Compensation Disclosure Tally Sheets
Target Awards Target Bonus Percentage Base Salary
Term Termination Termination Benefit Account
Termination Manufacturing Supply Agreement Advanced Medical Optics Termination Merger
Terms Debt Agreements Impose Restrictions Failure Comply Result Top-heavy Rules
Topical Aesthetic Skin Care Tpp
Trademark Assignment Trademark Assignment Agreement
Trademark Domain Name Assignment Trademarks
Transferability Awards Treasury Stock
Trust Fund Matching Contributions Unable Obtain Maintain Adequate Protection Intellectual Property Rights
Unanticipated Changes Tax Rates Exposure Additional Income Liabilities Uncertainties Exist Integrating Business Operations Inamed Cornéal Esprit
Uncertainties Exist Integrating Business Operations Inamed Cornéal Own Unregistered Sales Equity Securities Proceeds
Urologics Valuation Qualifying Accounts
Vesting Exercise Awards Vesting Plan Accounts
Vote Vote Outstanding Shares
Vote Proxy Internet Telephone Please Not Mail Card What Equity Ownership Guidelines Place Officers Directors
What Objectives Compensation Programs What Perquisites Other Benefits Provide
What Policies Deductibility Compensation What Policies Place Respect Timing Equity Compensation Awards
What Retirement Plans Not Generally Available Employees What Severance Change Control Benefits Provide
What Stock Ownership Guidelines Place Officers Directors What Targets Compensation Committee Established Each Element
Witness Whereof Parties Executed Amendment Effective Date Allergan 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki